PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11093389

Briefing paper--Zyban.

R S Levine
View original source ↗Export metadata ↓

Abstract

Zyban is a drug, newly available on NHS prescription, to aid smoking cessation. Two clinical trials suggest superior efficacy to nicotine patches, however side-effects include xerostomia and its use may have an impact on oral health.

Explore related subjects

BupropionDopamine Uptake InhibitorsHumansSmoking CessationXerostomiaJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R S Levine. 2000-10-28. Briefing paper--Zyban.. https://pubmed.ncbi.nlm.nih.gov/11093389/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Tobacco cessation interventions in dental networks: a practice-based evaluation of the impact of education on provider knowledge, referrals, and pharmacotherapy use.

Tobacco is a significant risk factor for oral diseases. Dental care providers have the opportunity to inform patients about the risks associated with tobacco use and refer them to tobacco cessation resources. Although dental teams usually ask their patients about their tobacco use, most do not provide tobacco cessation counseling. This project involved four staff-model dental clinics and four contracted network dental clinics. Project goals were to 1) describe current practice patterns of tobacco cessation intervention, 2) increase the use of steps for treatment, known as the 5 As, recommended by the U.S. Public Health Service, 3) increase referrals to a tobacco helpline, and 4) increase use of pharmacotherapy for tobacco dependence treatment. The project included training and program support (e.g., sharing of project data, weekly newsletters, discussion at clinic meetings). Results indicate that this approach to addressing tobacco dependence in a dental clinic setting can effectively change dental provider knowledge and action.

Bupropion↗